ARK Genomic Revolution ETF
Actively managed ETF investing in companies involved in CRISPR gene editing, molecular diagnostics, targeted therapeutics, and agricultural biology. High-risk thematic bet on the genomics revolution.
Performance Analysis
Maximum Drawdown History
How far the ETF has fallen from its all-time high at each point. Deeper = more painful.
Rolling Returns
Annualized returns over rolling windows. Shows the range of outcomes depending on when you invested.
Key Facts
Who Is This ETF For?
Key Risks to Consider
• Market risk: equity values can drop 30-50% in severe bear markets.
• Non-UCITS: may have unfavorable tax treatment for non-US investors (US estate tax, withholding tax).
Similar ETFs
Vanguard Total World Stock ETF
Total World · Vanguard
Vanguard FTSE All-World UCITS ETF (Acc)
Total World (UCITS) · Vanguard
iShares Core MSCI World UCITS ETF (Acc)
Developed World (UCITS) · BlackRock
Vanguard FTSE All-World UCITS ETF (Acc) — USD
Total World (UCITS) · Vanguard
Related Tools
Data & Methodology
Metadata sourced from official issuer documentation. Price data from Yahoo Finance (monthly adjusted close, includes reinvested dividends and splits). AUM figures are approximate and updated quarterly.